Leerink Partnrs Analysts Raise Earnings Estimates for LRMR
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Leerink Partnrs upped their Q2 2025 EPS estimates for Larimar Therapeutics in a research report issued on Wednesday, April 30th. Leerink Partnrs analyst J. Park now anticipates that the company will post earnings of ($0.52) per share for the quarter, up from their prior estimate of ($0.61). […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Leerink Partnrs upped their Q2 2025 EPS estimates for Larimar Therapeutics in a research report issued on Wednesday, April 30th. Leerink Partnrs analyst J. Park now anticipates that the company will post earnings of ($0.52) per share for the quarter, up from their prior estimate of ($0.61). […]
